Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 407 | Longs Won 191/360 53% | Profit Factor 1.46 |
| Profitability | Shorts Won 0/47 0% | Standard Deviation $3,673.44 |
| Average Win $1,463.1 | Best Trade (Dec 21) $36,921.77 | Sharpe Ratio -104.99 |
| Average Loss -$888.32 | Worst Trade (Sep 28) -$40,047.42 | Z-Score -7.2 (100%) |
| Commissions $0 | Avg. Trade Length 1m 1w 3d | Expectancy $225.37 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | 0.05% | 0.3% | 1.22% | 3.89% | 10.36% | 24.21% | 51.19% |
| Consecutive Losing Trades | 216 | 195 | 173 | 151 | 130 | 108 | 87 | 65 | 43 | 22 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPG Ascentage Pharma Group International | 500.48 | $7,692.31 | $7,869.98 | - | $177.67 | 2.31% | +1.846% |
CYTK Cytokinetics, Incorporated | 124.17 | $7,692.31 | $7,629.6 | - | -$62.71 | -0.82% | +0.351% |
EWTX Edgewise Therapeutics Inc. | 206.84 | $7,692.31 | $8,203.2 | - | $510.89 | 6.64% | +0.89% |
FTH Faeth Therapeutics, Inc. | 409.17 | $7,692.31 | $7,197.22 | - | -$495.09 | -6.44% | +2.986% |
IDYA IDEAYA Biosciences Inc. | 234.16 | $7,692.31 | $7,807.05 | - | $114.74 | 1.49% | -3.947% |
KARD Kardigan Inc. | 590.35 | $7,692.31 | $7,606.71 | - | -$85.6 | -1.11% | +0.664% |
PVLA Palvella Therapeutics, Inc. | 63.94 | $7,692.31 | $8,083 | - | $390.69 | 5.08% | +1.047% |
RCUS Arcus Biosciences, Inc. | 347.75 | $7,692.31 | $6,412.57 | - | -$1,279.74 | -16.64% | -0.539% |
RVMD Revolution Medicines, Inc. | 43.22 | $7,692.31 | $7,932.64 | - | $240.33 | 3.12% | -1.856% |
RYTM Rhythm Pharmaceuticals, Inc. | 89.27 | $7,692.31 | $8,060.99 | - | $368.68 | 4.79% | +1.154% |
TNGX Tango Therapeutics, Inc. | 349.02 | $7,692.31 | $8,226.3 | - | $533.99 | 6.94% | +0.985% |
WVE Wave Life Sciences Ltd. | 2,457.61 | $7,692.31 | $7,925.78 | - | $233.47 | 3.04% | +1.415% |